Keywords: شاخص فعالیت بیماری کرون; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; FDA; Food and Drug Administration; IBD; inflammatory bowel disease; PRO; patient-reported outcomes; PROMIS; Patient-Reported Outcomes Measurement Information System; UC; ulcerative colitis;
مقالات ISI شاخص فعالیت بیماری کرون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: شاخص فعالیت بیماری کرون; UNITI Trials; Inflammatory Bowel Disease Treatment; IBD; Anti-IL12/23; 6-MP; 6-mercaptopurine; AUC; area under the curve; AZA; azathioprine; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CRP; Creactive protein; ECLIA; electrochemilumines
Keywords: شاخص فعالیت بیماری کرون; Inflammatory Bowel Diseases; Hematopoietic Stem Cell Transplantation; Mesenchymal Stem Cell Transplantation; AD; adipocyte-derived; BM; bone marrow; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; HSCT; hematopoietic stem cell transplantati
Keywords: شاخص فعالیت بیماری کرون; CE; Capsule Endoscopy; CESI; Capsule Endoscopy Scoring Index; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CRP; C-reactive protein;
Keywords: شاخص فعالیت بیماری کرون; Diet; Amino Acid; Kynurenine; Inflammation; Anti-Inflammatory; AHR; aryl hydrocarbon receptor; AUC; area under the curve; CAI; Clinical Activity Index for Ulcerative Colitis; CARD9; caspase recruitment domain family member 9; CD; Crohn's disease; CDAI;
Keywords: شاخص فعالیت بیماری کرون; EEsAI; Remission; Endoscopic Grading; Disease Monitoring; AUC; area under the curve; CDAI; Crohn's Disease Activity Index; EEsAI; Eosinophilic Esophagitis Activity Index; EoE; eosinophilic esophagitis; EGD; esophagogastroduodenoscopy; hpf; high-power fi
Keywords: شاخص فعالیت بیماری کرون; Patient-Reported Outcomes; Telemedicine; Severity; Management; AUC; area under the curve; CD; Crohn's disease; CDAI; Crohn's disease activity index; DA-VAS; disease activity visual analogue scale; HBI; Harvey Bradshaw index; Hgb; hemoglobin; IBD; infl
Keywords: شاخص فعالیت بیماری کرون; Disease Severity; Disease Course; Inflammatory Bowel Disease; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CRP; C-reactive protein; ECCO; European Crohn's and Colitis Organisation; EIM; extraintestinal manifestation; ESR; erythrocyte s
Keywords: شاخص فعالیت بیماری کرون; AE; adverse event; CDAI; Crohn's Disease Activity Index; EIR; extended intestinal release; IBS; irritable bowel syndrome; IBS-D; diarrhea-predominant irritable bowel syndrome;
Keywords: شاخص فعالیت بیماری کرون; Inflammatory Bowel Disease; Diagnostic; Imaging; Monitoring; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CDEIS; Crohn's Disease Endoscopic Index of Severity; CI; confidence interval; GELS; Global Evaluation of Lesion; ICC; intraclass
Keywords: شاخص فعالیت بیماری کرون; Inflammatory Bowel Disease; Fecal Biomarkers; Prognostic Factor; Prognosis; AUROC; area under the receiver operator characteristic; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CDEIS; Crohn's Disease Endoscopic Index of Severity; CRP;
Keywords: شاخص فعالیت بیماری کرون; Comparative Effectiveness; Network Meta-Analysis; Crohn's Disease; Postoperative Prophylaxis; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; CrI; credible interval; ITT; intention-to-treat; RCT; randomized contro
Keywords: شاخص فعالیت بیماری کرون; Network Meta-analysis; IBD; Anti-TNF Therapy; Immunosuppressive Agents; CDAI; Crohn's Disease Activity Index; CrI; credible interval; OR; odds ratio; TNF; tumor necrosis factor; WDAE; withdrawals due to adverse events;
Keywords: شاخص فعالیت بیماری کرون; IBD; Immune Suppression; Clinical Trial; Inflammatory Bowel Disease; ACCENT; A Crohn's Disease Clinical Trial Evaluating Infliximab in a New Long-term Treatment Regimen; CDAI; Crohn's Disease Activity Index; CI; confidence interval; IM; immunomodulator;
Keywords: شاخص فعالیت بیماری کرون; Cell Therapy; Perianal Fistulas; Treatment; Inflammatory Bowel Disease; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; IL; interleukin; LUMC; Leiden University Medical Center; MRI; magnetic resonance imaging; MSC; mesenchymal stromal cell;
Keywords: شاخص فعالیت بیماری کرون; ADA; adalimumab; CD; Crohn disease; CDAI; Crohn's Disease Activity Index; CrI; credible interval; CZP; certolizumab pegol; HR; hazard ratio; IBD; inflammatory bowel disease; IFX; infliximab; IL-12/23; interleukin 12/23; NAT; natalizumab; OR; odds ratio;
Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD)
Keywords: شاخص فعالیت بیماری کرون; Contrast enhanced ultrasonography; Crohn's disease activity index; Inflammatory Bowel Disease;
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Keywords: شاخص فعالیت بیماری کرون; Combined Remission; Clinical Remission; Anal Fistula; Cell Therapy; CDAI; Crohn's Disease Activity Index; CI; confidence interval; Cx601; allogeneic; expanded; adipose-derived stem cells; IBDQ; inflammatory bowel disease questionnaire; LOCF; last observ
American Gastroenterological Association Institute Technical Review on the Management of Crohn's Disease After Surgical Resection
Keywords: شاخص فعالیت بیماری کرون; AGA; American Gastroenterological Association; 5-ASA; 5-aminosalicylate; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; GRADE; Grading of Recommendations Assessment, Development and Evaluation; NMA; network meta-an
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study
Keywords: شاخص فعالیت بیماری کرون; IL23; IL22; Clinical Trial; Phase II; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; CRP; C-reactive protein; IL; interleukin; IRB; Institutional Review Board; TNF; tumor necrosis factor;
Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases
Keywords: شاخص فعالیت بیماری کرون; Herbal Medicine; Acupuncture; Exercise; Probiotics; CAM; complementary and alternative medicine; CB; cannabinoid; CD; Crohn's disease; CDAI; Crohn's disease activity index; EPA; eicosapentaenoic acid; EPIC; Epanova Program in Crohn's Study; IBD; infla
Original ResearchFull Report: Clinical-Alimentary TractInfliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection
Keywords: شاخص فعالیت بیماری کرون; PREVENT; Anti-TNF; Inflammatory Bowel Disease; CDAI; ARR; absolute risk reduction; ATI; antibodies to infliximab; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; TNF; tumor necrosis factor;
Development of the Lémann Index to Assess Digestive Tract Damage in Patients With Crohn's Disease
Keywords: شاخص فعالیت بیماری کرون; Illness Index Severity; MRI; Response to Therapy; Prognosis; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CI; confidence interval; CT; computed tomography; DVD; digital versatile disc; ICC; intraclass correlation coefficient; IPNIC; Inte
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn's Disease
Keywords: شاخص فعالیت بیماری کرون; Tofacitinib; CP-690,550; Crohn's Disease; Randomized Control Trial; AE; adverse event; ANC; absolute neutrophil count; CDAI; Crohn's Disease Activity Index; CI; confidence interval; CRP; C-reactive protein; HDL; high-density lipoprotein; IBDQ; Inflamm
Original ResearchFull Report: Clinical-Alimentary TractEffects of Vedolizumab Induction Therapy for Patients With Crohn's Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
Keywords: شاخص فعالیت بیماری کرون; Anti-α4β7 Integrin; Anti-TNF Therapy; Randomized Controlled Trial; Lymphocyte Trafficking; AE; adverse event; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CDAI-100; CDAI score decrease of 100 points or more from baseline; CI; confide
Original ResearchFull Report: Clinical-Alimentary TractEarly Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
Keywords: شاخص فعالیت بیماری کرون; Inflammatory Bowel Disease; IBD; Comparison of Treatment Strategies; Drug; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; IBDQ; Inflammatory Bowel Disease Questionnaire; IQR; interquartile range; TNF; tumor necrosis factor;
A Crohn's Disease Patient Who Does Not Respond to Infliximab: What Is Next?
Keywords: شاخص فعالیت بیماری کرون; ATI; antibodies to infliximab; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CMV; cytomegalovirus; CRP; C-reactive protein; PML; progressive multifocal leukoencephalopathy; TNF; tumor necrosis factor;
A Randomized, Double-Masked, Placebo-Controlled Study of Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule 1, for the Treatment of Subjects With Active Crohn's Disease
Keywords: شاخص فعالیت بیماری کرون; AUC; area under the curve; CDAI; Crohn's disease activity index; CRM; clinical remission; CRP; C-reactive protein; ICAM-1; intercellular adhesion molecule 1; TNF; tumor necrosis factor.;
Serotonin Synthesis and Uptake in Symptomatic Patients With Crohn's Disease in Remission
Keywords: شاخص فعالیت بیماری کرون; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CDEIS; Crohn's Disease Endoscopic Index of Severity; EC; enterochromaffin; GI; gastrointestinal; 5-HT; serotonin; IBD; inflammatory bowel disease; IBS; irritable bowel syndrome; PCR; polymer
Onercept for Moderate-to-Severe Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Keywords: شاخص فعالیت بیماری کرون; AACD; acute active Crohn's disease; CACD; chronic active Crohn's disease; CD; Crohn's disease; CDAI; Crohn's disease activity index; CRP; C-reactive protein; TBP-1; TNF-binding protein 1; TNF; tumor necrosis factor.;
Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Keywords: شاخص فعالیت بیماری کرون; ALT; alanine transaminase; AST; aspartate transaminase; CD; Crohn's disease; CDAI; Crohn's disease activity index; CRP; C-reactive protein; IL; interleukin; MAPK; mitogen-activated protein kinase; RA; rheumatoid arthritis; TNF; tumor necrosis factor;
Magnetic Resonance Imaging Compared With Ileocolonoscopy in Evaluating Disease Severity in Crohn's Disease
Keywords: شاخص فعالیت بیماری کرون; CDAI; Crohn's disease activity index; CDEIS; Crohn's disease endoscopic index of severity; CRP; C-reactive protein; IS; ileocolonoscopy; MRI; magnetic resonance imaging; MRIend based; MRI endoscopy-based grading;